Anders Martin-Löf

Anders Martin-Löf is currently serving as an Independent Director at Cantargia AB, a Director at Oncopeptides Incentive AB, a Director at Lisa Martin-Löf Konsultbyrå AB, a Director at Affibody Medical AB, and will be the Chief Financial Officer & Secretary at BioArctic AB starting in 2023.
Previously, he held the position of Chief Financial Officer & Deputy CEO at Oncopeptides AB from 2018 to 2021.
He also served as a Director of Investor Relations at Biovitrum AB, a Director at Sciencecap Stockholm AB, the CFO, Investor Relations & Press Contact at RaySearch Laboratories AB from 2014 to 2015, the Chief Financial Officer at Extenda AB, the Head of Investor Relations at Swedish Orphan Biovitrum AB from 2006 to 2007, the Chief Financial Officer at Wilson Therapeutics AB from 2015 to 2018, and the Chief Financial Officer at A3P Biomedical AB (publ).
Mr. Martin-Löf obtained his undergraduate degree from the University of Stockholm, his graduate degree from the Royal Institute of Technology, and another graduate degree from ENSIMAG.